A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 799-805

  Bendall, Richard ^a   Ellis, Vic ^a   Ijaz, Samreen ^b   Ali, Rachel ^a   Dalton, Harry ^a  

^a ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Comparison; EIA; Hepatitis E; Seropositivity; Validation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; BLOOD DONOR; DEVELOPED COUNTRY; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; SEROPREVALENCE; UNITED KINGDOM; VALIDATION STUDY; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; DEVELOPED COUNTRIES; FEMALE; GREAT BRITAIN; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS E VIRUS;

EID: 77951015275     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21656     Document Type: Article

References (34)

1. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitisEvirus genotype 3 infection: IgGquantitation, avidity, and IgM response. J Med Virol 80:95-101. (Pubitemid 350220094)
2. Bernal W, Smith HM, Williams R. 1996. A community prevalence study of antibodies to hepatitis A and E in inner-city London. JMed Virol 49:230-234. (Pubitemid 26291389)
3. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. 2007. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 45:2009-2010. (Pubitemid 46933947)
4. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP, Frankena K, Husman AM, De Jong MC, Van Der Poel WH. 2008. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epidemiol Infect 136:567-576.
5. Buti M, Jardi R, Cotrina M, Rodriguez-Frias F, Troonen H, Viladomiu L, Esteban JI, Esteban R, Guardia J. 1995. Hepatitis E virus infection in acute hepatitis in Spain. J Virol Methods 55:49-54.
6. Buti M, Dominguez A, Plans P, Jardi R, Schaper M, Espunes J, Cardenosa N, Rodriguez-Frias F, Esteban R, Plasencia A, Salleras L. 2006. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 13: 1328-1332.
7. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, Purcell RH. 2008. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: A potential zoonosis in Denmark. Clin Infect Dis 47:1026-1031.
8. Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred S, Schroeder B, Croxson MC, Garkavenko O. 2007. Hepatitis E in New Zealand. J Gastroenterol Hepatol 22:1236-1240.
9. Dalton HR, Bendall R, Ijaz S, Banks M. 2008a. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis 8:698-709.
10. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, Farrington L, Hamad N, Sieberhagen C, Ellis V, Mitchell J, Hussaini SH, BanksM, Ijaz S, Bendall RP. 2008b. Autochthonous hepatitis E in Southwest England: Natural history, complications and seasonal variation, and hepatitis E virus IgGseroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 20:784-790.
11. Ding X, Li TC, Hayashi S, Masaki N, Tran TH, Hirano M, Yamaguchi M, Usui M, Takeda N, AbeK. 2003. Present state of hepatitis E virus epidemiology in Tokyo, Japan. Hepatol Res 27:169-173.
12. Drobeniuc J, Favorov MO, Shapiro CN, Bell BP, Mast EE, Dadu A, Culver D, Iarovoi P, Robertson BH, Margolis HS. 2001. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 184:1594-1597. (Pubitemid 33139746)
13. Ferguson M, Walker D, Mast E, Fields H. 2002. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals 30:43-48. (Pubitemid 34076370)
14. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP. 2007. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 14:562-568.
15. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. 2009. Indigenous hepatitis E virus infection in England: More common than it seems. J Clin Virol 44:272-276.
16. Karetnyi YV, Gilchrist MJ, Naides SJ. 1999. Hepatitis E virus infection prevalence among selected populations in Iowa. J Clin Virol 14: 51-55. (Pubitemid 29454637)
17. Lavanchy D, Morel B, Frei PC. 1994. Seroprevalence of hepatitis E virus in Switzerland. Lancet 344:747-748.
18. Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH, Xia NS. 2005. A bacterially expressed particulate hepatitis E vaccine: Antigenicity, immunogenicity and protectivity on primates. Vaccine 23:2893-2901.
19. Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, Zhang J, Ng MH, Xia NS. 2006. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 12:1682-1688. (Pubitemid 44674243)
20. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H, Destruel F, Izopet J. 2008. High prevalence of antihepatitis E virus antibodies in blood donors from South West France. J Med Virol 80:289-293.
21. Mateos ML, Camarero C, Lasa E, Teruel JL, Mir N, Baquero F. 1998. Hepatitis E virus: Relevance in blood donors and other risk groups. Vox Sang 75:267-269. (Pubitemid 29017353)
22. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. 2002. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 40:117-122. (Pubitemid 34027611)
23. Moaven L, Van Asten M, Crofts N, Locarnini SA. 1995. Seroepidemiology of hepatitis E in selected Australian populations. J Med Virol 45:326-330.
24. Myint KS, Endy TP, Gibbons RV, Laras K, Mammen MP, Jr., Sedyaningsih ER, Seriwatana J, Glass JS, Narupiti S, Corwin AL. 2006. Evaluation of diagnostic assays for hepatitis E virus in outbreak settings. J Clin Microbiol 44:1581-1583.
25. Olsen B, Axelsson-Olsson D, Thelin A, Weiland O. 2006. Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis 38:55-58. (Pubitemid 43123844)
26. Pavia M, Iiritano E, Veratti MA, Angelillo IF. 1998. Prevalence of hepatitis E antibodies in healthy persons in southern Italy. Infection 26:32-35. (Pubitemid 28062157)
27. Rapicetta M, Kondili LA, Pretolani S, Stroffolini T, Chionne P, Villano U, Madonna E, Casali F, Gasbarrini G. 1999. Seroprevalence and anti-HEV persistence in the general population of the Republic of San Marino. J Med Virol 58:49-53. (Pubitemid 29172120)
28. Stefanidis I, Zervou EK, Rizos C, Syrganis C, Patsidis E, Kyriakopoulos G, Sdrakas L, Tsianas N, Rigopoulou EI, Liakopoulos V, Dalekos GN. 2004. Hepatitis E virus antibodies in hemodialysis patients: An epidemiological survey in central Greece. Int J Artif Organs 27:842-847.
29. Sylvan SP, Jacobson SH, Christenson B. 1998. Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden. JMed Virol 54:38-43. (Pubitemid 28059061)
30. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. 1997. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 35:1244-1247. (Pubitemid 27175259)
31. Yan Q, Du H, Wang Y, Ge S, Huang S, Jiang L, Zhang J, Xia NS. 2008. Comparison of two diagnostic reagents to detect anti-hepatitis E virus IgG antibodies. Chin J Zoonoses 24:1087-1089.
32. Zaaijer HL, Kok M, Lelie PN, Timmerman RJ, Chau K, van der Pal HJ. 1993. Hepatitis E in the Netherlands: Imported and endemic. Lancet 341:826.
33. Zanetti AR, Dawson GJ. 1994. Hepatitis type E in Italy: A seroepidemiological survey. Study Group of Hepatitis. Eur J Med Virol 42: 318-320.
34. Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, Chau TN, Lai ST, Im SW. 2001. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 64:125-132.